RPID

Rapid Micro Biosystems, Inc. [RPID] Stock Forecast

Q: What is Rapid Micro Biosystems, Inc. stock symbol ?

Rapid Micro Biosystems, Inc. is a US stock, located in Lowell of Ma and trading under the symbol RPID

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

RPID Stock Summary

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 quarters (Quarter statements)

RPID has less than 1 year of cash runway

Top 10 Correlated Stocks

RPID

In the News

09:48 26 Mar 2023 RPID

Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of -2.63% and 1.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

04:05 26 Mar 2023 RPID

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023

LOWELL, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2022 financial results prior to the market open on Friday, March 3, 2023.

08:00 26 Mar 2023 RPID

Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference

LOWELL, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the 41st Annual J.P. Morgan Healthcare Conference.

01:03 26 Mar 2023 RPID

Rapid Micro Biosystems, Inc. (RPID) Q3 2022 Earnings Call Transcript

Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Mike Beaulieu - Investor Relations Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Rachel Vatnsdal - JPMorgan Stephanie Yan - Cowen Operator Hello. My name is Lisa and I will be your conference operator today.

09:47 26 Mar 2023 RPID

Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of -2.70% and 20.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

09:10 26 Mar 2023 RPID

Hill International, Rapid Micro Biosystems See Activist Investor Action

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.

11:03 26 Mar 2023 RPID

Rapid Micro Biosystems, Inc. (RPID) CEO Rob Spignesi on Q2 2022 Results - Earnings Call Transcript

Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q2 2022 Earnings Conference Call August 12, 2022 8:30 AM ET Company Participants Mike Beaulieu - CFA Vice President, Investor Relations & Corporate Communications Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Dan Arias - Stifel Stephanie Yan - Cowen Rachel Cascio - JPMorgan Operator Ladies and gentlemen, thank you for standing by and welcome to the Rapid Micro Biosystems Second Quarter 2022 Earnings Conference Call. I would now like to turn the call over to Mike Beaulieu, Investor Relations.

09:47 26 Mar 2023 RPID

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Lags Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of 11.43% and 24.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

01:51 26 Mar 2023 RPID

Rapid Micro Biosystems Inc. (RPID) CEO Robert Spignesi on Q1 2022 Results - Earnings Call Transcript

Rapid Micro Biosystems Inc. (NASDAQ:RPID ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Michael Beaulieu - CFA Vice President, Investor Relations and Corporate Communications Robert Spignesi - President and Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Noah Burhance - JPMorgan Operator Good day, and thank you for standing by. Welcome to the Rapid Micro Biosystems First Quarter 2022 Earnings Conference Call.

04:10 26 Mar 2023 RPID

Rapid Micro Biosystems to Announce First Quarter 2022 Financial Results on May 10, 2022

LOWELL, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2022 financial results on Tuesday, May 10, 2022, prior to the market open.

RPID Financial details

Company Rating

Neutral

Market Cap

52.74M

Income

-60.81M

Revenue

17.13M

Book val./share

3.87

Cash/share

2.56

Dividend

Dividend %

Employees

202

Optionable

Shortable

Yes

Earnings

03 Mar 2023

P/E

-0.9

Forward P/E

PEG

0.36

P/S

2.96

P/B

0.3

P/C

0.49

P/FCF

-0.8

Quick Ratio

7.86

Current Ratio

9.5

Debt / Equity

0.16

LT Debt / Equity

0.04

EPS (TTM)

-1.43

EPS next Y

EPS next Q

EPS this Y

-24.79%

EPS next Y

EPS next 5Y

EPS last 5Y

Revenue last 5Y

Revenue Q/Q

-7.7%

EPS Q/Q

2.63%

SMA20

10.26%

SMA50

-2.27%

SMA100

-58.65%

Inst Own

57.63%

Inst Trans

-2.7%

ROA

-29%

ROE

-29%

ROC

-0.32%

Gross Margin

-47%

Oper. Margin

-337%

Profit Margin

-328%

Payout

Shs Outstand

42.19M

Shs Float

13.74M

Target Price

52W Range

1.01-7.12

52W High

-82.14%

52W Low

+25%

RSI

48.96

Rel Volume

0.46

Avg Volume

93.96K

Volume

43.62K

Perf Week

3.31%

Perf Month

Perf Quarter

-61.3%

Perf Half Y

-64.29%

Beta

Volatility

0.08%, 0.11%

Prev Close

0.81%

Price

1.25

Change

-1.65%

RPID Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	0.61	0.6	0.86	0.4
Net income per share	-0.79	-1.38	-2.73	-1.43
Operating cash flow per share	-0.78	-1.15	-2.04	-1.38
Free cash flow per share	-0.85	-1.18	-2.04	-1.54
Cash per share	0.46	1.67	7.18	2.56
Book value per share	-0.03	0.92	8.2	3.87
Tangible book value per share	-0.03	0.92	8.2	3.87
Share holders equity per share	-0.03	0.92	8.2	3.87
Interest debt per share	0.75	1.05	-0.1	0.23
Market cap	577.01M	577.01M	286.89M	47.97M
Enterprise value	582.35M	571.74M	108.5M	28.88M
P/E ratio	-27.25	-15.56	-3.9	-0.79
Price to sales ratio	34.94	35.89	12.35	2.8
POCF ratio	-27.29	-18.62	-5.22	-0.82
PFCF ratio	-25.26	-18.21	-5.22	-0.73
P/B Ratio	-795.87	23.25	1.3	0.29
PTB ratio	-795.87	23.25	1.3	0.29
EV to sales	35.27	35.56	4.67	1.69
Enterprise value over EBITDA	-34.44	-17.87	-1.46	-0.51
EV to operating cash flow	-27.54	-18.45	-1.97	-0.49
EV to free cash flow	-25.49	-18.04	-1.97	-0.44
Earnings yield	-0.04	-0.06	-0.26	-1.27
Free cash flow yield	-0.04	-0.05	-0.19	-1.36
Debt to equity	-44.71	1.82	0.09	0.16
Debt to assets	1.02	0.65	0.08	0.14
Net debt to EBITDA	-0.32	0.16	2.39	0.34
Current ratio	2.24	4	12.01	7.27
Interest coverage	-7.85	-8.86	17.82	-35.56
Income quality	1	0.84	0.75	0.96
Dividend Yield	0	0	0	0
Payout ratio	0	0	0	0
Sales general and administrative to revenue	0.54	0.62	0.77	1.57
Research and developement to revenue	0.33	0.41	0.42	0.75
Intangibles to total assets	0	0	0	0
Capex to operating cash flow	0.08	0.02	0	0.12
Capex to revenue	-0.1	-0.04	0	-0.39
Capex to depreciation	-1.16	-0.46	-0.01	-2.38
Stock based compensation to revenue	0.03	0.03	0.08	0.23
Graham number	0.69	5.34	22.42	11.16
ROIC	-5.34	-5.71	0.4	-0.48
Return on tangible assets	-0.67	-0.53	-0.3	-0.32
Graham Net	-0.5	0.32	6.86	2.28
Working capital	13.08M	46.61M	199.96M	119.53M
Tangible asset value	-725K	24.82M	220.98M	164.17M
Net current asset value	-8.8M	16.97M	197.94M	112.1M
Invested capital	-24.56	1	0	0.05
Average receivables	0	5.35M	5.39M	5.19M
Average payables	0	3.84M	4.21M	4.69M
Average inventory	0	7.36M	12.32M	18.43M
Days sales outstanding	108.74	131.32	78.63	114.38
Days payables outstanding	69.99	67.53	46.48	77.17
Days of inventory on hand	125.37	135.51	184.67	301.22
Receivables turnover	3.36	2.78	4.64	3.19
Payables turnover	5.22	5.4	7.85	4.73
Inventory turnover	2.91	2.69	1.98	1.21
ROE	29.2	-1.49	-0.33	-0.37
Capex per share	-0.06	-0.03	0	-0.16

Quarterly Fundamentals Overview

Last date of statement is 2022-12-31 for Q4

Metric	2021-12-31	2022-03-31	2022-06-30	2022-09-30	2022-12-31
Revenue per share	0.12	0.1	0.09	0.11	0.1
Net income per share	-0.35	-0.35	-0.31	-0.38	-0.39
Operating cash flow per share	-0.31	-0.4	-0.35	-0.36	-0.27
Free cash flow per share	-0.31	-0.45	-0.4	-0.39	-0.29
Cash per share	4.62	3.84	3.39	2.7	2.56
Book value per share	5.28	4.91	4.59	4.21	3.87
Tangible book value per share	5.28	4.91	4.59	4.21	3.87
Share holders equity per share	5.28	4.91	4.59	4.21	3.87
Interest debt per share	0	0.19	0.2	0.21	0.21
Market cap	445.37M	286.52M	182.72M	137.33M	47.97M
Enterprise value	266.98M	232.03M	141.46M	119.72M	28.88M
P/E ratio	-7.62	-4.8	-3.49	-2.1	-0.73
Price to sales ratio	85.52	68.88	47.34	28.98	10.97
POCF ratio	-34.56	-17.05	-12.19	-9.09	-4.12
PFCF ratio	-34.56	-14.96	-10.76	-8.23	-3.85
P/B Ratio	2.02	1.38	0.94	0.77	0.29
PTB ratio	2.02	1.38	0.94	0.77	0.29
EV to sales	51.26	55.78	36.65	25.26	6.6
Enterprise value over EBITDA	-18.88	-16.19	-10.87	-7.97	-1.96
EV to operating cash flow	-20.72	-13.81	-9.44	-7.93	-2.48
EV to free cash flow	-20.72	-12.11	-8.33	-7.17	-2.32
Earnings yield	-0.03	-0.05	-0.07	-0.12	-0.34
Free cash flow yield	-0.03	-0.07	-0.09	-0.12	-0.26
Debt to equity	0.09	0.11	0.11	0.13	0.16
Debt to assets	0.08	0.1	0.1	0.11	0.14
Net debt to EBITDA	12.62	3.8	3.17	1.17	1.29
Current ratio	12.01	12.57	13.45	9.5	7.27
Interest coverage	766.11	-1.36K	-1.41K	-29.37	-20.77
Income quality	0.88	1.13	1.14	0.92	0.71
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	1.11	1.46	1.66	1.52	1.63
Research and developement to revenue	0.55	0.85	0.77	0.63	0.78
Intangibles to total assets	0	0	0	0	0
Capex to operating cash flow	0	0.14	0.13	0.11	0.07
Capex to revenue	0	-0.57	-0.52	-0.33	-0.19
Capex to depreciation	0	-4.2	-2.91	-2.16	-0.94
Stock based compensation to revenue	0.13	0.24	0.33	0.14	0.25
Graham number	6.44	6.25	5.64	6.03	5.81
ROIC	0.12	-0.15	-0.12	-0.12	-0.13
Return on tangible assets	-0.06	-0.06	-0.06	-0.08	-0.09
Graham Net	4.42	3.58	3.22	2.49	2.28
Working capital	199.96M	172.03M	158.73M	129.37M	119.53M
Tangible asset value	220.98M	207.07M	194.97M	179.02M	164.17M
Net current asset value	197.94M	163.92M	150.31M	121.68M	112.1M
Invested capital	0	0.04	0.04	0.05	0.05
Average receivables	5.01M	4.54M	4.2M	4.52M	5.04M
Average payables	3.1M	3.75M	3.19M	3.25M	4.55M
Average inventory	14.92M	16.69M	19.5M	21.11M	21.06M
Days sales outstanding	86.49	88.2	100.87	89.53	110.47
Days payables outstanding	45.54	52.51	49.99	43.85	70.04
Days of inventory on hand	180.96	262	377.16	249.99	273.38
Receivables turnover	1.04	1.02	0.89	1.01	0.81
Payables turnover	1.98	1.71	1.8	2.05	1.29
Inventory turnover	0.5	0.34	0.24	0.36	0.33
ROE	-0.07	-0.07	-0.07	-0.09	-0.1
Capex per share	0	-0.06	-0.05	-0.04	-0.02

RPID Frequently Asked Questions

What is Rapid Micro Biosystems, Inc. stock symbol ?

Rapid Micro Biosystems, Inc. is a US stock , located in Lowell of Ma and trading under the symbol RPID

Is Rapid Micro Biosystems, Inc. buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $8. The lowest prediction is $8 and the highest is $8

What is RPID stock prediction ?

What is Rapid Micro Biosystems, Inc. stock quote today ?

Rapid Micro Biosystems, Inc. stock price is $1.25 today.

Is Rapid Micro Biosystems, Inc. stock public?

Yes, Rapid Micro Biosystems, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 93.96K
Market Capitalization 52.74M
Employee 202
CEO Mr. Robert G. Spignesi Jr.
Headquarters Lowell,MA,US
IPO Date 2017-01-24
Website https://www.rapidmicrobio.com

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.